Related Experiment Video
Updated: Feb 28, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[Rapid tranquillisation for agitated patients with psychostimulant intoxication]
Intravenous droperidol appears more effective for sedating patients with psychostimulant intoxication than lorazepam. However, current research is limited, requiring more studies to confirm optimal psychopharmacological treatments for agitation.
Area of Science:
- Emergency Medicine
- Clinical Pharmacology
- Toxicology
Background:
- Psychostimulant intoxication poses significant health risks, necessitating prompt medical surveillance and sedation.
- Aggression and agitation are common complications requiring effective management strategies.
Purpose of the Study:
- To evaluate the scientific evidence for psychopharmacological interventions in managing aggression and agitation in psychostimulant-intoxicated patients.
- To identify the most effective medications for rapid tranquilization in this patient population.
Main Methods:
- Systematic literature search conducted to identify relevant studies.
- Analysis of available research on psychopharmacological treatments for psychostimulant intoxication.
Main Results:
- Intravenous droperidol demonstrated faster and more effective sedation compared to intravenous lorazepam in psychostimulant-intoxicated patients.
- Limitations in existing studies include small sample sizes and insufficient patient population detail, hindering definitive conclusions.
Conclusions:
- Current research is insufficient to provide convincing evidence for the optimal psychopharmacological treatment of aggression in psychostimulant intoxication.
- Further rigorous studies are needed to establish best practices for managing agitated patients with psychostimulant intoxication.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...